Dr. Graeme Ladds | Director of Pharmacovigilance & Chief Executive Officer
PharSafer

Dr. Graeme Ladds, Director of Pharmacovigilance & Chief Executive Officer, PharSafer

With a first degree in Biochemistry & Pharmacology and a PhD focussing on drug metabolism and Pharmacokinetics Graeme has worked in the areas of Drug Safety and Medical services for over 30 years.

Graeme has been working as Head of Global Pharmacovigilance and EU QP PV for many top 10 Pharma Companies (and small) Pharma, and has been CEO for the last 19 years for PharSafer®. Graeme is also a member of the DIA; TOPRA; RQA and the Institute of Directors and PIPA and has helped small start-up Companies (Biotech; Medical Devices; Biologics; Generics; Herbal; OTC) in their planning, growth and been involved in Company and product acquisitions, due diligence activities for product in-licensing and marketing and development strategies with partner and distributor Companies. Graeme has been involved in many drug development programmes, taking products from the bench to market in a wide range of therapeutic areas. Graeme also has an additional role as Research & Development Director for products to be developed for global launches.

Appearances:



World Drug Safety Congress Americas 2022 Day 1 @ 11:40

Case processing – the most important part of pharmacovigilance?

last published: 01/Oct/22 14:05 GMT

back to speakers

Get Involved At Drug Safety Congress Americas

 

To Sponsor Or Exhibit


Semen Sen
Semen.sen@terrapinn.com
t/ +1 646 619 1793

 

 

To Speak


Gina McHugh
gina.mchugh@terrapinn.com
t/ +1 646 619 1775

 

 

Marketing & Press Opportunities


Taylor Post
taylor.post@terrapinn.com
t/ +1 646 619 1785